...
首页> 外文期刊>International journal of clinical pharmacy. >Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
【24h】

Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.

机译:巴基斯坦医院内科病房中潜在的药物相互作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Multiple drugs therapies may be the potential source of drug-drug interactions that can result in alteration of therapeutic response and/or increase untoward effects of many drugs.To identify the frequency and levels of potential drug-drug interactions (pDDIs) in internal medicine wards and their association with patients' age, gender, length of hospital stay and number of prescribed medications; and to describe management of frequently identified major or moderate pDDIs.Internal medicine wards of two major tertiary care hospitals of Khyber Pakhtunkhwa, Pakistan.Micromedex Drug-Reax system was used to screen patient's profiles for pDDIs. Logistic regression was applied to determine the odds ratio for specific risk factors of pDDIs i.e., age, gender, hospital-stay and number of medications.Overall prevalence and prevalence of contraindicated, major, moderate and minor pDDIs; levels of pDDIs; frequently identified major or moderate interactions; and odds ratios for risk factors.Total, 188 interacting drug-combinations were identified that contributed to 675 pDDIs. Of 400 patients, 52.8% patients were presented with at least one pDDI (overall prevalence), 21.3% with at least one major-pDDI, and 44.3% with at least one moderate-pDDI. Of 675 pDDIs, most were of moderate (63.6%) or major severity (23%); good (61.2%) or fair (25.5%) type of scientific evidence; and delayed onset (50.2%). Most frequently identified major or moderate interactions resulted in 45.3% of all pDDIs. Their potential adverse outcomes included hepatotoxicity, bleeding, ototoxicity, nephrotoxicity, hypoglycemia, hyperglycemia, risk of thrombosis, hypotension, cardiac arrhythmias and reduction in therapeutic-effectiveness. There was significant association of the occurrence of pDDIs with patients' age of 60 years or more (OR = 2.1; 95% CI = 1.3-3.3; p = 0.003), hospital stay of 6 days or longer (OR = 2.6; 95% CI = 1.5-4.5; p = 0.001), and seven or more number of prescribed medications (OR = 5.9; 95% CI = 3.6-9.6; p < 0.001).The present study has recorded a high prevalence of pDDIs in internal medicine wards. Patients with old age, longer hospital stay and increased number of prescribed medications were at higher risk.
机译:多种药物疗法可能是药物-药物相互作用的潜在来源,可能导致治疗反应的改变和/或增加许多药物的不良作用。确定内部药物病房中潜在药物-药物相互作用(pDDI)的频率和水平与患者的年龄,性别,住院时间和处方药数量之间的关系;巴基斯坦开伯尔·普赫图赫瓦(Khyber Pakhtunkhwa)两家主要三级护理医院的内科病房。MicromedexDrug-Reax系统用于筛查患者的pDDIs。应用Logistic回归确定特定pDDI危险因素的比值比,即年龄,性别,住院天数和用药次数。禁忌,主要,中度和次要pDDI的总体患病率和患病率; pDDI的水平;经常发现主要或中等程度的互动;总共确定了188种相互作用的药物组合,构成675个pDDI。在400例患者中,有52.8%的患者至少出现一种pDDI(总体患病率),21.3%的患者出现至少一种主要pDDI,44.3%的患者出现至少一种中度pDDI。在675个pDDI中,大多数为中度(63.6%)或严重度(23%);良好(61.2%)或公平(25.5%)类型的科学证据;并延迟发作(50.2%)。最常见的主要或中度相互作用导致了所有pDDI的45.3%。它们的潜在不良后果包括肝毒性,出血,耳毒性,肾毒性,低血糖,高血糖,血栓形成的风险,低血压,心律不齐和治疗效果的降低。 pDDIs的发生与60岁或更高年龄的患者(OR = 2.1; 95%CI = 1.3-3.3; p = 0.003),住院6天或更长时间(OR = 2.6; 95%)有显着相关性CI = 1.5-4.5; p = 0.001),以及七种或更多处方药(OR = 5.9; 95%CI = 3.6-9.6; p <0.001)。本研究表明内科药物中pDDI的患病率很高病房。年龄较大,住院时间较长和处方药数量增加的患者处于较高的风险中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号